TY - JOUR
T1 - Zolpidem, triazolam, and temazepam
T2 - Behavioral and subject-rated effects in normal volunteers
AU - Rush, Craig R.
AU - Griffiths, Roland R.
PY - 1996
Y1 - 1996
N2 - Zolpidem is an imidazopyridine hypnotic that is biochemically distinct from classic benzodiazepine agonists in that it-may be selective for the BZ1 receptor subtype and shows a (different pattern of distribution of binding sites. The present study compared the learning, recall, performance, subjectrated and observer-rated effects of zolpidem, triazolam, and temazepam in 11 healthy humans. Placebo, zolpidem (5,10, and 20 mg/70 kg), triazolam (0.125, 0.25, and 0.50 mg/70 kg), and temazepam (15, 30, and 60 mg/70 kg) were administered orally in a randomized, double-blind, crossover design. Zolpidem, triazolam, and temazepam produced orderly dose- and time-related impairment of learning, recall, and performance, and increased subject- and observer-rated estimates of strength of drug effect. The absolute magnitude of these effects at peak effect were comparable across the three compounds. The time to maximal drug effect was faster with zolpidem (0.5-1.0 hours) than with triazolam (1.5-2.0 hours) = or temazepam (2-3 hours). These results suggest that despite the somewhat unique benzodiazepine receptor-binding profile of zolpidem, its behavioral and subject-rated effects are similar to those of benzodiazepine hypnotics (i.e., triazolam and temazepam).
AB - Zolpidem is an imidazopyridine hypnotic that is biochemically distinct from classic benzodiazepine agonists in that it-may be selective for the BZ1 receptor subtype and shows a (different pattern of distribution of binding sites. The present study compared the learning, recall, performance, subjectrated and observer-rated effects of zolpidem, triazolam, and temazepam in 11 healthy humans. Placebo, zolpidem (5,10, and 20 mg/70 kg), triazolam (0.125, 0.25, and 0.50 mg/70 kg), and temazepam (15, 30, and 60 mg/70 kg) were administered orally in a randomized, double-blind, crossover design. Zolpidem, triazolam, and temazepam produced orderly dose- and time-related impairment of learning, recall, and performance, and increased subject- and observer-rated estimates of strength of drug effect. The absolute magnitude of these effects at peak effect were comparable across the three compounds. The time to maximal drug effect was faster with zolpidem (0.5-1.0 hours) than with triazolam (1.5-2.0 hours) = or temazepam (2-3 hours). These results suggest that despite the somewhat unique benzodiazepine receptor-binding profile of zolpidem, its behavioral and subject-rated effects are similar to those of benzodiazepine hypnotics (i.e., triazolam and temazepam).
UR - http://www.scopus.com/inward/record.url?scp=0029881707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029881707&partnerID=8YFLogxK
U2 - 10.1097/00004714-199604000-00007
DO - 10.1097/00004714-199604000-00007
M3 - Article
C2 - 8690830
AN - SCOPUS:0029881707
SN - 0271-0749
VL - 16
SP - 146
EP - 157
JO - Journal of Clinical Psychopharmacology
JF - Journal of Clinical Psychopharmacology
IS - 2
ER -